180 related articles for article (PubMed ID: 22315499)
1. A novel, highly sensitive and rapid allele-specific loop-mediated amplification assay for the detection of the JAK2V617F mutation in chronic myeloproliferative neoplasms.
Minnucci G; Amicarelli G; Salmoiraghi S; Spinelli O; Guinea Montalvo ML; Giussani U; Adlerstein D; Rambaldi A
Haematologica; 2012 Sep; 97(9):1394-400. PubMed ID: 22315499
[TBL] [Abstract][Full Text] [Related]
2. Two-round allele specific-polymerase chain reaction: a simple and highly sensitive method for JAK2V617F mutation detection.
Kannim S; Thongnoppakhun W; Auewarakul CU
Clin Chim Acta; 2009 Mar; 401(1-2):148-51. PubMed ID: 19135044
[TBL] [Abstract][Full Text] [Related]
3. Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms.
Hu L; Pu L; Ding Y; Li M; Cabanero M; Xie J; Zhou D; Yang D; Zhang C; Wang H; Zhai Z; Ru X; Li J; Xiong S
Hematology; 2017 Jul; 22(6):354-360. PubMed ID: 27976991
[TBL] [Abstract][Full Text] [Related]
4. A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.
Denys B; El Housni H; Nollet F; Verhasselt B; Philippé J
J Mol Diagn; 2010 Jul; 12(4):512-9. PubMed ID: 20431031
[TBL] [Abstract][Full Text] [Related]
5. Melting curve analysis after T allele enrichment (MelcaTle) as a highly sensitive and reliable method for detecting the JAK2V617F mutation.
Morishita S; Takahashi K; Araki M; Hironaka Y; Sunami Y; Edahiro Y; Tsutsui M; Ohsaka A; Tsuneda S; Komatsu N
PLoS One; 2015; 10(3):e0122003. PubMed ID: 25794279
[TBL] [Abstract][Full Text] [Related]
6. JAK2V617F allele burden in patients with myeloproliferative neoplasms.
Alshemmari SH; Rajaan R; Ameen R; Al-Drees MA; Almosailleakh MR
Ann Hematol; 2014 May; 93(5):791-6. PubMed ID: 24362471
[TBL] [Abstract][Full Text] [Related]
7. [Detection of JAK2V617F mutation rate by real-time fluorescent quantitative PCR using allele specific primer and TaqMan-MGB probe for dual inhibiting amplification of wild type alleles].
Liang GW; Shao DH; He ML; Cao QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1486-91. PubMed ID: 23257459
[TBL] [Abstract][Full Text] [Related]
8. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
9. JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.
Edahiro Y; Morishita S; Takahashi K; Hironaka Y; Yahata Y; Sunami Y; Shirane S; Tsutsui M; Noguchi M; Koike M; Imai K; Kirito K; Noda N; Sekiguchi Y; Tsuneda S; Ohsaka A; Araki M; Komatsu N
Int J Hematol; 2014; 99(5):625-34. PubMed ID: 24677207
[TBL] [Abstract][Full Text] [Related]
10. A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms.
Fantasia F; Di Capua EN; Cenfra N; Pessina G; Mecarocci S; Rago A; Cotroneo E; Busanello A; Equitani F; Lo-Coco F; Nervi C; Cimino G
Ann Hematol; 2014 Apr; 93(4):609-16. PubMed ID: 24173087
[TBL] [Abstract][Full Text] [Related]
11. Development of a highly sensitive method for detection of JAK2V617F.
Zhao AH; Gao R; Zhao ZJ
J Hematol Oncol; 2011 Oct; 4():40. PubMed ID: 21985400
[TBL] [Abstract][Full Text] [Related]
12. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
13. [JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhu JF; Liu Y; Liu P; Jia MF; Cheng J; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):916-20. PubMed ID: 21867614
[TBL] [Abstract][Full Text] [Related]
14. Highly Sensitive Blocker Displacement Amplification for Detection of Low-Level JAK2V617F Variant.
Wang Z; Weller C; Pinto A; Zhang DY; Mularo F; Tu ZJ; Cheng YW
J Appl Lab Med; 2023 May; 8(3):479-490. PubMed ID: 36759689
[TBL] [Abstract][Full Text] [Related]
15. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.
Lippert E; Girodon F; Hammond E; Jelinek J; Reading NS; Fehse B; Hanlon K; Hermans M; Richard C; Swierczek S; Ugo V; Carillo S; Harrivel V; Marzac C; Pietra D; Sobas M; Mounier M; Migeon M; Ellard S; Kröger N; Herrmann R; Prchal JT; Skoda RC; Hermouet S
Haematologica; 2009 Jan; 94(1):38-45. PubMed ID: 19001280
[TBL] [Abstract][Full Text] [Related]
16. JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate.
Nielsen C; Bojesen SE; Nordestgaard BG; Kofoed KF; Birgens HS
Haematologica; 2014 Sep; 99(9):1448-55. PubMed ID: 24907356
[TBL] [Abstract][Full Text] [Related]
17. [Detection of JAK2V617F mutation in patients with myeloproliferative disorders with TaqMan-MGB probe].
Ruan GR; Chen SS; Li LD; Liu YR; Qin YZ; Li JL; Ma X; Wang FR; Jiang Q; Jiang B; Liu KY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2401-4. PubMed ID: 18036317
[TBL] [Abstract][Full Text] [Related]
18. [Detection and clinical significance of JAK2 mutation in 412 patients with chronic myeloproliferative neoplasms].
Chao HY; Fan Z; Zhang R; Shen YM; Chen W; Fei HR; Zhu ZL; Feng YF; Chen ZX; Xue YQ
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):510-4. PubMed ID: 19950698
[TBL] [Abstract][Full Text] [Related]
19. JAK2V617F mutation in patients with splanchnic vein thrombosis.
Xavier SG; Gadelha T; Pimenta G; Eugenio AM; Ribeiro DD; Gomes FM; Bonamino M; Zalcberg IR; Spector N
Dig Dis Sci; 2010 Jun; 55(6):1770-7. PubMed ID: 19690956
[TBL] [Abstract][Full Text] [Related]
20. [Tyrosine kinase JAK2V617F mutation in human myeloproliferative disorders].
Xu YY; Li HM; Li XJ; Yang L; Hu DM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):541-4. PubMed ID: 19549360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
